Kcnab2 Rat 1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene multiple interactions ISO Kcnab2 (Mus musculus) 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Kcnab2 Rat 1,2-dimethylhydrazine increases expression ISO Kcnab2 (Mus musculus) 6480464 1,2-Dimethylhydrazine results in increased expression of KCNAB2 mRNA CTD PMID:22206623 Kcnab2 Rat 1-O-palmitoyl-2-O-(5-oxovaleryl)-sn-glycero-3-phosphocholine multiple interactions EXP 6480464 [KCNAB2 protein co-treated with NADP] results in increased reduction of 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine CTD PMID:21296056 Kcnab2 Rat 17beta-estradiol multiple interactions ISO KCNAB2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of KCNAB2 mRNA CTD PMID:30165855 Kcnab2 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Kcnab2 (Mus musculus) 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Kcnab2 Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Kcnab2 (Mus musculus) 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Kcnab2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KCNAB2 mRNA CTD PMID:34747641 Kcnab2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of KCNAB2 mRNA CTD PMID:33387578 Kcnab2 Rat 2,4,4'-trichlorobiphenyl multiple interactions ISO Kcnab2 (Mus musculus) 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Kcnab2 Rat 3,4-methylenedioxymethamphetamine increases expression ISO Kcnab2 (Mus musculus) 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of KCNAB2 mRNA CTD PMID:20188158 Kcnab2 Rat 4,4'-sulfonyldiphenol decreases methylation ISO Kcnab2 (Mus musculus) 6480464 bisphenol S results in decreased methylation of KCNAB2 promoter CTD PMID:33297965 Kcnab2 Rat 4,4'-sulfonyldiphenol multiple interactions ISO KCNAB2 (Homo sapiens) 6480464 [bisphenol S co-treated with Fulvestrant] results in increased methylation of KCNAB2 gene CTD PMID:31601247 Kcnab2 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of KCNAB2 mRNA CTD PMID:24780913 Kcnab2 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of KCNAB2 mRNA CTD PMID:31881176 Kcnab2 Rat aflatoxin B1 affects methylation ISO KCNAB2 (Homo sapiens) 6480464 Aflatoxin B1 affects the methylation of KCNAB2 intron CTD PMID:30157460 Kcnab2 Rat Aflatoxin B2 alpha increases methylation ISO KCNAB2 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of KCNAB2 intron CTD PMID:30157460 Kcnab2 Rat all-trans-retinoic acid decreases expression ISO KCNAB2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of KCNAB2 mRNA CTD PMID:15498508 Kcnab2 Rat alpha-Zearalanol increases expression EXP 6480464 Zeranol results in increased expression of KCNAB2 mRNA CTD PMID:35163327 Kcnab2 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of KCNAB2 mRNA CTD PMID:16483693 Kcnab2 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of KCNAB2 mRNA CTD PMID:30779732 Kcnab2 Rat antirheumatic drug decreases expression ISO KCNAB2 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of KCNAB2 mRNA CTD PMID:24449571 Kcnab2 Rat arsane affects methylation ISO KCNAB2 (Homo sapiens) 6480464 Arsenic affects the methylation of KCNAB2 gene CTD PMID:25304211 Kcnab2 Rat arsenic atom affects methylation ISO KCNAB2 (Homo sapiens) 6480464 Arsenic affects the methylation of KCNAB2 gene CTD PMID:25304211 Kcnab2 Rat benzo[a]pyrene decreases methylation ISO KCNAB2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of KCNAB2 3' UTR; Benzo(a)pyrene results in decreased methylation of more ... CTD PMID:27901495 Kcnab2 Rat benzo[a]pyrene affects methylation ISO KCNAB2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of KCNAB2 5' UTR; Benzo(a)pyrene affects the methylation of KCNAB2 intron; more ... CTD PMID:27901495|PMID:30157460 Kcnab2 Rat benzo[a]pyrene decreases methylation ISO Kcnab2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of KCNAB2 intron CTD PMID:27901495 Kcnab2 Rat benzo[e]pyrene increases methylation ISO KCNAB2 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of KCNAB2 intron; benzo(e)pyrene results in increased methylation of KCNAB2 more ... CTD PMID:30157460 Kcnab2 Rat beta-lapachone increases expression ISO KCNAB2 (Homo sapiens) 6480464 beta-lapachone results in increased expression of KCNAB2 mRNA CTD PMID:38218311 Kcnab2 Rat bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of KCNAB2 mRNA CTD PMID:20920545 Kcnab2 Rat bis(2-ethylhexyl) phthalate increases expression ISO Kcnab2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of KCNAB2 mRNA CTD PMID:32235866 Kcnab2 Rat bisphenol A increases methylation ISO KCNAB2 (Homo sapiens) 6480464 bisphenol A results in increased methylation of KCNAB2 gene CTD PMID:22576693 Kcnab2 Rat bisphenol A multiple interactions ISO KCNAB2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of KCNAB2 gene CTD PMID:31601247 Kcnab2 Rat bisphenol A increases expression ISO Kcnab2 (Mus musculus) 6480464 bisphenol A results in increased expression of KCNAB2 mRNA CTD PMID:31250031|PMID:38701888 Kcnab2 Rat bisphenol A increases expression ISO KCNAB2 (Homo sapiens) 6480464 bisphenol A results in increased expression of KCNAB2 mRNA CTD PMID:29275510|PMID:36385337 Kcnab2 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of KCNAB2 gene CTD PMID:28505145 Kcnab2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KCNAB2 mRNA CTD PMID:25181051 Kcnab2 Rat bisphenol A decreases expression ISO KCNAB2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of KCNAB2 mRNA CTD PMID:22576693 Kcnab2 Rat buta-1,3-diene decreases expression ISO Kcnab2 (Mus musculus) 6480464 1,3-butadiene results in decreased expression of KCNAB2 mRNA CTD PMID:29038090 Kcnab2 Rat Butylbenzyl phthalate decreases methylation ISO Kcnab2 (Mus musculus) 6480464 butylbenzyl phthalate results in decreased methylation of KCNAB2 intron CTD PMID:28392331 Kcnab2 Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of KCNAB2 mRNA CTD PMID:33453195 Kcnab2 Rat cadmium dichloride increases expression ISO KCNAB2 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of KCNAB2 mRNA CTD PMID:38568856 Kcnab2 Rat caffeine affects phosphorylation ISO KCNAB2 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of KCNAB2 protein CTD PMID:35688186 Kcnab2 Rat calciol decreases expression ISO Kcnab2 (Mus musculus) 6480464 Cholecalciferol results in decreased expression of KCNAB2 mRNA CTD PMID:16508948 Kcnab2 Rat carmustine affects response to substance ISO KCNAB2 (Homo sapiens) 6480464 KCNAB2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 Kcnab2 Rat choline multiple interactions ISO Kcnab2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Kcnab2 Rat cisplatin decreases expression ISO KCNAB2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of KCNAB2 mRNA CTD PMID:27594783 Kcnab2 Rat cisplatin multiple interactions ISO KCNAB2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of KCNAB2 mRNA CTD PMID:27392435 Kcnab2 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of KCNAB2 mRNA CTD PMID:26577399 Kcnab2 Rat dioxygen decreases expression ISO Kcnab2 (Mus musculus) 6480464 Oxygen results in decreased expression of KCNAB2 mRNA CTD PMID:25447406 Kcnab2 Rat doxorubicin decreases expression ISO KCNAB2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of KCNAB2 mRNA CTD PMID:29803840 Kcnab2 Rat epoxiconazole increases expression ISO Kcnab2 (Mus musculus) 6480464 epoxiconazole results in increased expression of KCNAB2 mRNA CTD PMID:35436446 Kcnab2 Rat etoposide affects response to substance ISO KCNAB2 (Homo sapiens) 6480464 KCNAB2 protein affects the susceptibility to Etoposide CTD PMID:16217747 Kcnab2 Rat folic acid multiple interactions ISO Kcnab2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Kcnab2 Rat fulvestrant multiple interactions ISO KCNAB2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of KCNAB2 gene; [bisphenol S co-treated more ... CTD PMID:31601247 Kcnab2 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of KCNAB2 mRNA CTD PMID:33387578 Kcnab2 Rat L-methionine multiple interactions ISO Kcnab2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Kcnab2 Rat methapyrilene increases methylation ISO KCNAB2 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of KCNAB2 intron; Methapyrilene results in increased methylation of KCNAB2 more ... CTD PMID:30157460 Kcnab2 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of KCNAB2 gene CTD PMID:35440735 Kcnab2 Rat methyl methanesulfonate decreases expression ISO KCNAB2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of KCNAB2 mRNA CTD PMID:23649840 Kcnab2 Rat mitoxantrone affects response to substance ISO KCNAB2 (Homo sapiens) 6480464 KCNAB2 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 Kcnab2 Rat N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of KCNAB2 gene CTD PMID:33148267 Kcnab2 Rat NADP zwitterion affects binding EXP 6480464 NADP binds to KCNAB2 protein CTD PMID:19013139 Kcnab2 Rat NADP zwitterion multiple interactions EXP 6480464 [KCNAB2 protein co-treated with NADP] results in increased reduction of 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine; [KCNAB2 protein co-treated with more ... CTD PMID:21296056 Kcnab2 Rat NADP(+) affects binding EXP 6480464 NADP binds to KCNAB2 protein CTD PMID:19013139 Kcnab2 Rat NADP(+) multiple interactions EXP 6480464 [KCNAB2 protein co-treated with NADP] results in increased reduction of 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine; [KCNAB2 protein co-treated with more ... CTD PMID:21296056 Kcnab2 Rat nickel atom increases expression ISO KCNAB2 (Homo sapiens) 6480464 Nickel results in increased expression of KCNAB2 mRNA CTD PMID:24768652|PMID:25583101 Kcnab2 Rat okadaic acid decreases expression ISO KCNAB2 (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of KCNAB2 mRNA CTD PMID:38832940 Kcnab2 Rat ozone multiple interactions ISO Kcnab2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... CTD PMID:34911549 Kcnab2 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of KCNAB2 mRNA CTD PMID:33387578 Kcnab2 Rat PCB138 multiple interactions ISO Kcnab2 (Mus musculus) 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Kcnab2 Rat permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of KCNAB2 gene CTD PMID:33148267 Kcnab2 Rat silicon dioxide increases expression ISO KCNAB2 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of KCNAB2 mRNA CTD PMID:25895662 Kcnab2 Rat silicon dioxide increases expression ISO Kcnab2 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of KCNAB2 mRNA CTD PMID:29341224 Kcnab2 Rat sodium arsenate increases expression ISO Kcnab2 (Mus musculus) 6480464 sodium arsenate results in increased expression of KCNAB2 mRNA CTD PMID:39847705 Kcnab2 Rat sodium arsenite decreases methylation ISO KCNAB2 (Homo sapiens) 6480464 sodium arsenite results in decreased methylation of KCNAB2 gene CTD PMID:24570342 Kcnab2 Rat sodium arsenite increases expression ISO KCNAB2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of KCNAB2 mRNA CTD PMID:24570342|PMID:38568856 Kcnab2 Rat sulforaphane increases expression ISO KCNAB2 (Homo sapiens) 6480464 sulforaphane results in increased expression of KCNAB2 mRNA CTD PMID:31838189 Kcnab2 Rat tamibarotene affects expression ISO KCNAB2 (Homo sapiens) 6480464 tamibarotene affects the expression of KCNAB2 mRNA CTD PMID:15498508 Kcnab2 Rat temozolomide affects response to substance ISO KCNAB2 (Homo sapiens) 6480464 KCNAB2 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 Kcnab2 Rat tert-butyl hydroperoxide increases expression ISO Kcnab2 (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of KCNAB2 mRNA CTD PMID:15003993 Kcnab2 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of KCNAB2 mRNA CTD PMID:31150632 Kcnab2 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of KCNAB2 mRNA CTD PMID:34492290 Kcnab2 Rat thiram increases expression ISO KCNAB2 (Homo sapiens) 6480464 Thiram results in increased expression of KCNAB2 mRNA CTD PMID:38568856 Kcnab2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of KCNAB2 mRNA CTD PMID:33387578 Kcnab2 Rat triclosan increases expression ISO KCNAB2 (Homo sapiens) 6480464 Triclosan results in increased expression of KCNAB2 mRNA CTD PMID:30510588 Kcnab2 Rat triphenyl phosphate affects expression ISO KCNAB2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of KCNAB2 mRNA CTD PMID:37042841 Kcnab2 Rat triptonide increases expression ISO Kcnab2 (Mus musculus) 6480464 triptonide results in increased expression of KCNAB2 mRNA CTD PMID:33045310 Kcnab2 Rat trovafloxacin decreases expression ISO Kcnab2 (Mus musculus) 6480464 trovafloxacin results in decreased expression of KCNAB2 mRNA CTD PMID:35537566 Kcnab2 Rat tungsten decreases expression ISO Kcnab2 (Mus musculus) 6480464 Tungsten results in decreased expression of KCNAB2 mRNA CTD PMID:30912803 Kcnab2 Rat urethane decreases expression ISO KCNAB2 (Homo sapiens) 6480464 Urethane results in decreased expression of KCNAB2 mRNA CTD PMID:28818685 Kcnab2 Rat valproic acid increases methylation ISO KCNAB2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of KCNAB2 gene CTD PMID:29154799